ALKERMES | ALKS - Текущие активы





Текущие активы Изменить Дата
AbbVie USD 33.67B 140M 2026-06
Acadia Pharmaceuticals USD 1.22B 128.53M 2026-06
ALKERMES USD 1.52B 164.26M 2026-06
Amgen USD 34.96B 3.49B 2026-06
Biogen USD 7.58B 278.7M 2026-09
BioMarin Pharmaceutical USD 3.97B 633.45M 2026-06
Bristol-Myers Squibb USD 29.77B 1.19B 2026-09
Coherus Biosciences USD 133.79M 72.25M 2026-06
Eli Lilly USD 65.26B 591M 2026-09
Gilead Sciences USD 16.55B 4.02B 2026-09
Heron Therapeutics USD 229.84M 861K 2026-06
Ionis Pharmaceuticals USD 2.49B 446.73M 2026-06
J&J USD 56.35B 3.42B 2026-09
Malin Corporation EUR 62.6M 26.7M 2024-12
Merck USD 36.68B 1.66B 2026-06
Minerva Neurosciences USD 83.1M 70.08M 2025-12
Nektar Therapeutics USD 589.04M 322.77M 2026-03
Neurocrine Biosciences USD 1.64B 798.6M 2026-06
Otsuka Holdings JPY 1.63T 30.58B 2026-06
Ovoca Bio EUR 2.07M 510K 2025-12
Pfizer USD 41.36B 1.46B 2026-06
Regeneron Pharmaceuticals USD 20.8B 2.35B 2026-09
Vertex Pharmaceuticals USD 12.54B 813.4M 2026-06